Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
株式のランク
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
株価
$3.40
時価総額
$9.07B
変化（1日）
-1.61%
変化（1年）
-16.08%
国
CN
取引 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
カテゴリー
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の配当利回りの履歴
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（銘柄コード: 600196）の配当利回り（TTM）は2024-12-31時点で3.11%です。
過去5年間の平均配当利回り: 2.09%
過去5年間の平均配当利回り: 2.09%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の2001から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 1.72% | 43.33% |
| 2025 | 1.20% | -61.41% |
| 2024 | 3.11% | -15.49% |
| 2023 | 3.68% | 135.90% |
| 2022 | 1.56% | 77.27% |
| 2021 | 0.88% | 22.22% |
| 2020 | 0.72% | -40.00% |
| 2019 | 1.20% | -63.30% |
| 2018 | 3.27% | 149.62% |
| 2017 | 1.31% | -41.26% |
| 2016 | 2.23% | 8.78% |
| 2015 | 2.05% | 3.02% |
| 2014 | 1.99% | 8.15% |
| 2013 | 1.84% | -24.90% |
| 2012 | 2.45% | -8.58% |
| 2011 | 2.68% | 127.12% |
| 2010 | 1.18% | 6.31% |
| 2009 | 1.11% | -43.65% |
| 2008 | 1.97% | 58.87% |
| 2007 | 1.24% | -82.18% |
| 2006 | 6.96% | 48.72% |
| 2005 | 4.68% | 38.05% |
| 2004 | 3.39% | 59.15% |
| 2003 | 2.13% | -2.29% |
| 2002 | 2.18% | 44.37% |
| 2001 | 1.51% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 3.18% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
